1. Home
  2. ONC vs OTIS Comparison

ONC vs OTIS Comparison

Compare ONC & OTIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • OTIS
  • Stock Information
  • Founded
  • ONC 2010
  • OTIS 1853
  • Country
  • ONC Switzerland
  • OTIS United States
  • Employees
  • ONC N/A
  • OTIS N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • OTIS Consumer Electronics/Appliances
  • Sector
  • ONC Health Care
  • OTIS Technology
  • Exchange
  • ONC Nasdaq
  • OTIS Nasdaq
  • Market Cap
  • ONC 34.8B
  • OTIS 35.5B
  • IPO Year
  • ONC N/A
  • OTIS N/A
  • Fundamental
  • Price
  • ONC $368.19
  • OTIS $88.97
  • Analyst Decision
  • ONC Strong Buy
  • OTIS Hold
  • Analyst Count
  • ONC 12
  • OTIS 8
  • Target Price
  • ONC $361.00
  • OTIS $103.88
  • AVG Volume (30 Days)
  • ONC 252.8K
  • OTIS 2.3M
  • Earning Date
  • ONC 11-06-2025
  • OTIS 10-29-2025
  • Dividend Yield
  • ONC N/A
  • OTIS 1.89%
  • EPS Growth
  • ONC N/A
  • OTIS N/A
  • EPS
  • ONC 0.29
  • OTIS 3.39
  • Revenue
  • ONC $4,998,489,124.00
  • OTIS $14,310,000,000.00
  • Revenue This Year
  • ONC $887.89
  • OTIS $4.05
  • Revenue Next Year
  • ONC $22.45
  • OTIS $4.81
  • P/E Ratio
  • ONC $1,226.72
  • OTIS $26.20
  • Revenue Growth
  • ONC 49.15
  • OTIS 0.73
  • 52 Week Low
  • ONC $170.99
  • OTIS $84.25
  • 52 Week High
  • ONC $381.50
  • OTIS $106.83
  • Technical
  • Relative Strength Index (RSI)
  • ONC 66.75
  • OTIS 40.28
  • Support Level
  • ONC $306.60
  • OTIS $89.91
  • Resistance Level
  • ONC $381.50
  • OTIS $92.00
  • Average True Range (ATR)
  • ONC 12.71
  • OTIS 1.43
  • MACD
  • ONC 6.69
  • OTIS -0.31
  • Stochastic Oscillator
  • ONC 80.96
  • OTIS 1.15

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About OTIS Otis Worldwide Corporation

Otis is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis' founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.

Share on Social Networks: